This guideline covers the current state of molecular diagnostic techniques intended for the characterization of solid tumors, and covers a range of clinical applications including diagnosis, prognosis, therapeutic response prediction for available drugs and those still in clinical trials, as well as monitoring and presymptomatic and predisposition testing.
More Standards PDF
CSA B45.15-17/ASME A112.19.5-2017 (R2022)
$54.00 $108.00
CGA F-3
$19.00 $38.00
CSA C22.2 NO. 269.4-17 (R2022)
$75.00 $150.00
CSA Z364.6-17 (R2022)
$62.00 $125.00